{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T18:50:58Z","timestamp":1768675858210,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.yebeh.2017.05.033","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T20:18:43Z","timestamp":1498853923000},"page":"163-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Controversies in the treatment of seizures associated with neurocysticercosis"],"prefix":"10.1016","volume":"76","author":[{"given":"Gagandeep","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravina","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2017.05.033_bb0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1212\/01.wnl.0000168828.83461.09","article-title":"Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru","volume":"65","author":"Montano","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0010","doi-asserted-by":"crossref","first-page":"e1152","DOI":"10.1371\/journal.pntd.0001152","article-title":"Clinical manifestations associated with neurocysticercosis: a systematic review","volume":"5","author":"Carabin","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0015","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1212\/01.WNL.0000036320.69823.EA","article-title":"Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis","volume":"59","author":"Carpio","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0020","first-page":"107","article-title":"Cysticercosis (Taenia solium) a further ten years' clinical study, covering 284 cases","volume":"13","author":"Dixon","year":"1944","journal-title":"QJM"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0025","first-page":"603","article-title":"Presentaction de un caso clinico de cisticercosis cerebral tratado medicamente con un Nuevo farmaco: Praziquantel","volume":"21","author":"Robles","year":"1979","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0030","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archinte.1987.00370040120021","article-title":"Albendazole therapy for neurocysticercosis","volume":"147","author":"Escobedo","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0035","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archinte.1985.00360030074016","article-title":"Neurocysticerosis: a new classification based on active and inactive forms. A study of 753 cases","volume":"145","author":"Sotelo","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0040","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/archneur.1982.00510210003001","article-title":"Cysticerocosis. An old scourge revisited","volume":"39","author":"Wiederholt","year":"1982","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0045","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1750-3639.1997.tb01083.x","article-title":"Neurocysticercosis","volume":"7","author":"Pittella","year":"1997","journal-title":"Brain Pathol"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0050","series-title":"The pathology of nervous system","first-page":"2507","article-title":"Cysticercosis","author":"Escobar","year":"1972"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0055","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/epi.12159","article-title":"From seizures to epilepsy and its substrates: neurocysticercosis","volume":"54","author":"Singh","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0060","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1528-1157.1998.tb01287.x","article-title":"Cysticrcosis and epilepsy: a critical review","volume":"39","author":"Carpio","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1017\/S0317167100048757","article-title":"A proposal for classification of neurocysticercosis","volume":"21","author":"Carpio","year":"1994","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0070","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1212\/01.WNL.0000129481.12067.06","article-title":"Calcific neurocysticercosis and epileptogenesis","volume":"62","author":"Nash","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0075","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S1474-4422(08)70243-6","article-title":"Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case- control study","volume":"7","author":"Nash","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3171\/jns.1987.66.3.0359","article-title":"Long-term results of praziquantel therapy in neurocysticercosis","volume":"66","author":"Robles","year":"1987","journal-title":"J Neurosurg"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0085","doi-asserted-by":"crossref","first-page":"752-725","DOI":"10.1212\/WNL.35.5.752","article-title":"Parziquantel in the treatment of neurocysticercosis: long-term follow-up","volume":"35","author":"Sotelo","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0090","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/archneur.1988.00520290064015","article-title":"Albendazole vs praziquantel for therapy for neurocysticercosis: a controlled trial","volume":"45","author":"Sotelo","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0095","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archneur.1988.00520340084017","article-title":"Short course of albendazole therapy for neurocysticercosis","volume":"45","author":"Sotelo","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMoa031294","article-title":"A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis","volume":"350","author":"Garcia","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0105","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/jnnp.2008.144899","article-title":"Effects of albendazole treatment on neurocysticercosis: a randomized controlled trial","volume":"79","author":"Carpio","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-3476(03)00211-7","article-title":"Efficacy of albendazole and short course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial","volume":"143","author":"Kalra","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0004418","article-title":"Albendazole and corticosteroids for the treatment of solitary cysticercus granuloma: a network meta-analysis","volume":"10","author":"Zhao","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0120","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1212\/WNL.0b013e31820202dc","article-title":"A diagnostic and therapeutic scheme for a solitary cysticercus granuloma","volume":"75","author":"Singh","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0125","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1600-0404.2005.00538.x","article-title":"Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma","volume":"113","author":"Verma","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0130","first-page":"141","article-title":"Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?","volume":"50","author":"Thussu","year":"2002","journal-title":"Neurol India"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0135","first-page":"145","article-title":"Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain","volume":"50","author":"Gupta","year":"2002","journal-title":"Neurol India"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0140","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0035-9203(03)90075-7","article-title":"Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double blind, placebo controlled trial in newly diagnosed cases","volume":"97","author":"Gogia","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0145","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1212\/WNL.44.7.1344","article-title":"Albendazole in single CT ring lesions in epilepsy","volume":"44","author":"Padma","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0150","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1586\/ern.11.86","article-title":"Corticosteroid use in neurocysticercosis","volume":"11","author":"Nash","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jinf.2005.09.002","article-title":"Short course of prednisolone in patients with solitary cycticercus granuloma: a double blind placebo controlled study","volume":"53","author":"Garg","year":"2006","journal-title":"J Infect"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0160","first-page":"419","article-title":"Short course of oral prednisolone on disappearance of lesion and seizure recurrence in patients of solitary cysticercal granuloma with single small enhancing CT lesion: an open randomized prospective study","volume":"55","author":"Kishore","year":"2007","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0165","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1046\/j.1528-1157.2003.08003.x","article-title":"Short course of prednisolone in Indian patients with solitary cysticercus granuloma and new- onset seizures","volume":"44","author":"Mall","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0170","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1528-1167.2011.03184.x","article-title":"Short course of prednisolone in solitary cysticercus granuloma: a randomized, double blind, placebo-controlled trial","volume":"52","author":"Singla","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0175","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/epi.12739","article-title":"Enhanced steroid dosing reduced seizures during antiparasitic treatment for cysticercosis and early after","volume":"55","author":"Garcia","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0180","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1212\/WNL.37.9.1561","article-title":"Plasma levels of praziquantel decrease when dexamethasone is given simultaneously","volume":"37","author":"Vazquez","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0185","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00314741","article-title":"Dexamethasone increases plasma levels of albendazole","volume":"237","author":"Jung","year":"1990","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0190","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1212\/WNL.42.3.492","article-title":"Phenytoin and carbamezapine decrease oral bioavailability of praziquantel","volume":"42","author":"Bittencourt","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0195","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00007691-200206000-00003","article-title":"Pharmacokinetic interaction between Albendazole sulfoxide enantiomers and antiepilepstic drugs in patients with Neurocysticercosis","volume":"24","author":"Lanchote","year":"2002","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0200","first-page":"331","article-title":"Cutaneous reactions in patients with solitary cysticercus granuloma on phenytoin sodium","volume":"75","author":"Singh","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2017.05.033_bb0205","first-page":"157","article-title":"Safety and efficacy of cobazam versus phenytoin-sodium in the antiepileptic drug treatment of solitary cysticercus granulomas","volume":"54","author":"Kaushal","year":"2006","journal-title":"Neurol India"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501730313X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501730313X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T14:32:21Z","timestamp":1535639541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550501730313X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":41,"alternative-id":["S152550501730313X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2017.05.033","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controversies in the treatment of seizures associated with neurocysticercosis","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2017.05.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}